pml

PatientsLikeMe Report: MS Patients Still Positive for Tysabri Following July Announcement of PML Cases

14 Comments / Patient Experiences, Research / By

PatientsLikeMe recently released a new PatientsLikeMeListen™ report: “Did the July 2008 PML announcement affect the Tysabri brand?” Among our findings, the report reveals that MS patients retained an overall positive perception of the Tysabri brand despite the July 2008 announcement of two additional PML cases. When we originally covered this topic back in August,  the […]

PatientsLikeMe Report: MS Patients Still Positive for Tysabri Following July Announcement of PML Cases Read More »

Tysabri and the 2 New Reported Cases of PML

7 Comments / Multiple Sclerosis, Research / By

Members of our Multiple Sclerosis (MS) community have been discussing this story in the Boston Globe which reports severe adverse events experienced by two European MS patients on the drug Tysabri (Natalizumab). Tysabri is a monoclonal antibody which seems to have a potent effect on MS; the original trial published in the New England Journal

Tysabri and the 2 New Reported Cases of PML Read More »

Scroll to Top